ONCOLOGY
22 Feb 2026

26 Jan 2026

22 Dec 2025

16 Dec 2025

26 Nov 2025

20 Nov 2025

20 Nov 2025

22 Sep 2025

17 Sep 2025

Expert Insight View All
Conference Update View All
Meeting Highlight View All
First glimpse of zolbetuximab-based chemo-immunotherapy shows promise in CLDN18.2- and PD-L1-positive advanced G/GEJ cancer: ILUSTRO phase 2 data from ASCO GI 2026
22 Feb 2026
Case Review View All
News & Perspective View All
Infographics View All
